Teva Pharm tops quarterly estimates but 2025 earnings outlook falls short
Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...
Jewish Telegraphic Agency7y
Israel-based Teva Pharmaceutical to lay off 14,000 workers as part of restructuring
JERUSALEM (JTA) — Israel-based Teva Pharmaceutical Industries, one of the largest manufacturers of generic drugs in the world, will lay off 14,000 workers as part of a global restructuring ...
BBC7y
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
Almost half of Teva's employees are based in Israel Israel's Teva Pharmaceutical Industries has announced a restructuring plan that will see it cut 14,000 jobs worldwide, or 25% of its total ...
JD Supra2d
Teva Announces New Biosimilar Deals
Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...
Business Insider18d
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) today announced that it has entered ...
Drug Store News10d
Teva partners with Klinge Biospharma, Formycon for Eylea biosimilar candidate in Europe, Israel
Teva Pharmaceuticals International GmbH ... excluding Italy, and in Israel. This collaboration combines Teva’s deep commercial experience in biosimilars and its extensive distribution network ...
Drugmaker Teva Pharmaceuticals fined $500M by European regulators
31 (UPI) --The European Commission fined Teva Pharmaceuticals $503 million for ... The multinational drug manufacturer ...
CNN4y
Teva Pharmaceutical Industries Limited Sponsored ADR
Teva Pharmaceutical Industries Ltd. engages in ... The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Financial Post18d
Teva Announces Collaboration to Commercialize Formycon's Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
TEL AVIV, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) today announced that it has ...